Skip to content
VuFind
Home
Contrast
0
Mindlist
(Full)
DE
|
EN
Find
Advanced Search
Search History
ILSE
Online articles
Phase I Study of Single-Agent...
Email Record
Email Record:
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
To:
CAPTCHA:
Please enter what you see:
Loading...